Congresswoman Anna Eshoo

Representing the 18th District of California

Eshoo Holds Legislative Hearing on Seven Bills to Improve Health Care Coverage and Outcomes

January 8, 2020
Press Release

WASHINGTON, D.C.— Today, Energy and Commerce Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) held a hearing on seven bills to improve health outcomes for kids and strengthen benefits and coverage for Medicare and Medicaid beneficiaries.

To watch Chairwoman Eshoo’s opening statement, click HERE.

“Last year, the Health Subcommittee was remarkably productive. We held 19 hearings and passed 31 bills with bipartisan support. Today, we build on that progress,” Chairwoman Eshoo said. “We examined seven bipartisan bills to improve Americans’ health care and coverage. I’m proud to be an original cosponsor of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act which extends Medicare coverage of post-transplant drugs for kidney transplant recipients to prevent a projected 375 failed kidney transplants a year. The six other bills address critical needs, from funding programs to improve birth outcomes in high-risk communities, to improving data collection to address Sudden Unexplained Death in Childhood (SUDC).”

The Subcommittee convened two panels during the hearing. The first considered legislative proposals to provide funding to improve the study and prevention of SUDC, award grants to schools to encourage better allergy and asthma treatment, and improve birth outcomes in high-risk communities. The panel included expert testimony from the President of the American Academy of Pediatrics, the President and CEO of the Asthma and Allergy Foundation of America, and an ambassador from the SUDC Foundation.

The second panel testified on legislation to require health plans to cover medically-necessary services for patients with congenital anomalies; protect Medicare beneficiaries from a lifetime of financial penalties for failure to enroll in Part B; require states to offer a non-emergency medical transportation benefit; and extend Medicare coverage of post-transplant drugs for kidney transplant recipients, which a nonpartisan HHS analysis found would save 375 kidney transplants each year. The second panel included expert testimony from the Director of Kidney and Pancreas Transplantation at Medstar Georgetown Transplant Institute, a patient advocate from the National Foundation for Ectodermal Dysplasias, and the President of Medicare Rights Center.

To read more about the legislation considered by the Subcommittee and to watch testimony from expert witnesses, click HERE.

###